Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott Acquires Kos Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News

Abbott Acquires Kos Pharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott has entered into a definitive agreement to acquire Kos Pharmaceuticals in a transaction valued at $3.7 billion. Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. Kos is based in Cranbury, NJ.

“Kos Pharmaceuticals is an excellent strategic fit for Abbott, both scientifically and commercially,” said Miles D. White, chairman and chief executive officer, Abbott. “This acquisition expands Abbott’s presence in the lipid management market and will provide several on-market and late-stage pipeline products. Kos also complements our existing commercial and research and development expertise, and increases our R&D spending capacity.”

“Since being founded in 1988 by our current chairman Emeritus Michael Jaharis and chairman Daniel Bell, Kos has pioneered the HDL therapy area in the U.S. and firmly established Niaspan and Advicor as successful and highly differentiated therapies,” said Adrian Adams, president and chief executive officer, Kos Pharmaceuticals. “This is an opportune time to become a part of another fast-growing organization like Abbott with the shared experience and additional resources to help capture the full value of our highly differentiated cholesterol franchise and our growing R&D pipeline.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters